News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Wayne Drevets, MD

Wayne Drevets, MD

Dr Drevets is vice president and neuropsychiatry disease area stronghold leader at Johnson & Johnson.

Articles by Wayne Drevets, MD

insomnia

Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New Data

ByLeah Kuntz,Andrew Krystal, MD,Wayne Drevets, MD

June 6th 2024

Andrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.

Latest Updated Articles

Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New Data
Published: June 6th 2024 | Updated:

© 2025 MJH Life Sciences^®

All rights reserved.